secwatch.observer — SEC 8-K summary
======================================

Issuer:     KINETA, INC./DE (—)
CIK:        0001445283
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0000950170-24-060408
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kineta Q1 2024 net loss $10.2M; cash $1.8M; going concern doubt; exploring strategic alternatives
--------------------------------------------------------------------------------

- Cash of $1.8M as of March 31, 2024, down from $5.8M at year-end 2023; received $500K from existing investor in April 2024.
- Net loss of $10.2M ($0.89 per share) vs. $6.5M ($0.77 per share) in Q1 2023; no revenue in Q1 2024.
- Substantial doubt about ability to continue as a going concern; actively exploring strategic alternatives to maximize stockholder value.
- Phase 1/2 VISTA-101 trial for KVA12123 shows partial response in combination cohort and durable stable disease; enrollment of new patients suspended.
- Company reduced workforce and suspended new patient enrollment after some investors failed to fund April 2024 private placement obligation; litigation pursued against larger non-funding investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1445283/000095017024060408/0000950170-24-060408-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1445283/000095017024060408/ka-20240515.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-060408

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer